Brain scan study for long COVID neurological symptoms
Part of Infections, Lungs & breathing clinical trials.
This study uses a special PET scan to look at brain inflammation in people with neurological symptoms after COVID-19. It aims to understand how inflammation might be linked to ongoing problems like brain fog or memory issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have ongoing neurological symptoms after COVID-19 that are part of a condition called neuro-PASC.
- You are enrolled in a related NIH study (Natural History of COVID Recovery or INPASC).
- You have had a COVID-19 infection at least six weeks ago and are no longer contagious.
- You cannot take NSAIDs (like ibuprofen) for 2 weeks before the scan, or steroids/immunosuppressants for 1 month before.
- You must be able to lie flat and still for at least 2 hours and have no metal in your body that interferes with MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies if brain scans can help understand 'brain fog' in Long COVID. It also looks at how a gentle magnetic stimulation might affect symptoms. If you have ongoing thinking problems after COVID, this study may help find new ways to help.
This study uses special imaging (PET/CT) to understand ongoing breathing problems or tiredness after COVID-19. It aims to learn how inflammation and changes in the body connect to symptoms that last more than 3 months.
This study uses brain scans to understand depression that starts soon after COVID-19. Researchers want to see if there are changes in brain chemistry related to depression, and you may help find new treatment targets.
This study is for veterans who have long COVID with brain or nerve symptoms. It looks at how the immune system may be causing these ongoing symptoms.
This trial uses brain scans to understand why people with long COVID feel very tired or have trouble thinking clearly. It could help find new treatments for these symptoms.
This study tests whether a drug called pembrolizumab (a type of immunotherapy) can help people with ongoing neurological symptoms after COVID-19. The goal is to see if it is safe and possibly improves symptoms like brain fog, fatigue, and dizziness.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.